Table 1.

Principal population features

Year of Radical Prostatectomy (range)	2002–2022
Initial PSA at Prostatectomy (median value, IQR)	8.1 ng/ml (IQR 5.4–11.6)
pT	T2: 27 (26%) T3a: 59 (56.7%) T3b: 18 (17.3)
pN	pN0:71 (68.3%) pN1: 6 (5.7%) pNx:27 (26%)
Initial Gleason Grade group	3 + 3: 4 (3.8%) 3 + 4: 28 (27%) 4 + 3: 33 (31.7%) 4 + 4: 24 (23%) 4 + 5: 13 (12.5%) 5 + 4: 2 (2%)
Surgical Margin status	R0: 50 R1: 54
Time between prostatectomy and recurrence (Median, IQR)	40 months (13-75.7)
Age (median value, IQR)	69 (62–72)
PSA at recurrence (median value, IQR)	0.39 ng/ml (IQR 0.29–0.51)
PSMA results	Negative/positive within prostate bed: 67 (64.4%)/8 (7.7%) Pelvic nodal disease: 23 (22.1%) Extrapelvic metastatic disease: 6 (5.8%)
Number of lesions	0: 75 (72.1%) 1: 23 (22.1%) > 1: 6 (5.8%)
Lesion site	Nodal: 22 (75.9%) Bone: 6 (20.7%) Visceral: 1 (3.4%)